Effect of Prescription Tongxin on Endothelial Progenitor Cells in Peripheral Blood.

Conclusions: Prescription Tongxin can stimulate the release of EPCs from the bone marrow to the peripheral blood of patients with CHD, can significantly increase the proliferation of EPCs in the peripheral blood, and can improve the clinical symptoms of patients. Its curative effect was greater than that of the control treatment. PMID: 32412917 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32412917?dopt=Abstract

Source: Alternative Therapies in Health and Medicine - May 14, 2020 Category: Complementary Medicine Authors: Liu Z, Wang W, Yang XQ, Fan J, Hu XZ, Wang YS, Wang S, Feng QM, Lu LH Tags: Altern Ther Health Med Source Type: research